Pharmacodynamic Study of dexmedetomidine sedation in children

Adequate sedation with single-dose Intranasal dexmedetomidine in pediatric patients undergoing electroencephalogram examination: a dose-response study in children under 3 years old

Status

Recruiting

Phases

Phase 4

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR1800015270

Enrollment

Unknown

Registered

2018-03-19

Start date

2018-03-25

Completion date

Unknown

Last updated

2018-03-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

congenital cardiovascular disease

Interventions

Case series:The sequential method of Intranasal dexmedetomidine

Eligibility

Sex/Gender

All

Age

1 Years to 3 Years

Inclusion criteria

Inclusion criteria: children under 3 years old and requiring dexmedetomidine for electroencephalogram to be classified as American Society of Anesthesiologists physical status I or II

Exclusion criteria

Exclusion criteria: 1. known allergy to dexmedetomidine; 2. recent treatment with a-2 adrenergic receptor agonist; 3. renal or hepatic dysfunction; 4. nasal discharges;

Design outcomes

Primary

Measure	Time frame
heart rate;Oxygen saturation;respiration rate;	—

Countries

China

Contacts

Public ContactTu Shengfen

Children's Hospital Affiliated Chongqing Medical University

519194496@qq.com+86 13983416114

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026